logo

For the Inventor, By the Inventor

Edogawa, Japan

Akihiro Imura

This inventor holds 7 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2005-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiro Imura. Retrieved from https://idiyas.com/inventor/akihiro-imura-pleh71z1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7

% Patents Active = 42.9

Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 15(Granted Patents)


Location History:

  • Edogawa-ku, JP (2005 - 2008)
  • Tokyo, JP (2007 - 2010)

Company Filing History:

goldMedal7 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents

Years Active: 2005-2010

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7678919 - Method for producing pentacyclic taxans (2010-03-16),
2. 7456302 - Method for producing pentacyclic taxans (2008-11-25),
3. 7217560 - Process for preparation of optically active propoxyaniline derivatives (2007-05-15),
4. 7189847 - Process for producing benzoxazine derivative and production intermediate thereof (2007-03-13),
5. 7126003 - Method for producing 2-azetidinone derivative (2006-10-24),
6. 7087778 - Process for producing benzoxazine derivative and production intermediate thereof (2006-08-08),
7. 6872823 - Process for producing benzoxazine derivative and production intermediate thereof (2005-03-29),

Title: Akihiro Imura: Innovator in Antitumor Compounds

Introduction

Akihiro Imura is a prominent inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds. With a total of 7 patents to his name, Imura's work has the potential to impact cancer treatment significantly.

Latest Patents

One of Imura's latest patents is a method for producing pentacyclic taxans. This innovative process allows for the efficient and inexpensive production of taxan derivatives, which are useful as oral-administrable antitumor compounds. The method involves processing a compound of formula (1) with an alkali metal permanganate to produce a compound of formula (2). This compound may serve as a starting material for developing oral-administrable antitumor compounds.

Career Highlights

Imura has dedicated his career to advancing pharmaceutical research and development. His work at Daiichi Pharmaceutical Co., Ltd. has positioned him as a key player in the industry. His innovative approaches to drug formulation and production have garnered attention and respect from his peers.

Collaborations

Throughout his career, Imura has collaborated with notable colleagues, including Yoshihiro Takayanagi and Kouji Sato. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Akihiro Imura's contributions to the field of pharmaceuticals, particularly in developing antitumor compounds, highlight his role as an influential inventor. His innovative methods and collaborative spirit continue to drive advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…